Rajin Kang
About Rajin Kang
Rajin Kang is the VP of Communications at BenevolentAI in London, with a background in science and health communications and a strong interest in transformative technologies.
Professional Background
Rajin Kang is currently the VP of Communications at BenevolentAI, a position she has held since July 2018. BenevolentAI, located in London, UK, focuses on applying Artificial Intelligence and Machine Learning to drug discovery. Rajin's work involves re-engineering the drug discovery process to deliver life-changing medicines, leveraging transformative technologies.
Prior Experience in Communications
Before joining BenevolentAI, Rajin Kang was the Senior Account Director at AxiCom from 2014 to 2018. At AxiCom, she honed her skills in managing high-level account communications. Prior to her role at AxiCom, she served as a Senior Account Manager at Platform PR from 2012 to 2014. Rajin also has experience as a Marketing Executive at GfK (Cogenta), where she worked from 2009 to 2012.
Educational Background
Rajin Kang completed her higher education at King's College London, where she studied Physiology, Anatomy, and Psychology, achieving a degree in Anatomy and Human Sciences from 2006 to 2009. Her foundational education was at Tiffin Girl's School, where she studied from 1999 to 2006.
Interest in Transformative Technologies
Rajin Kang has shown a strong interest in transformative technologies throughout her career. Her current role at BenevolentAI encapsulates this passion, as she works on applying advanced AI and machine learning techniques to revolutionize drug discovery and deliver innovative medical solutions.
Expertise in Science and Health Communications
With a background in science and health communications, Rajin Kang has effectively bridged her scientific knowledge with strategic communication roles. This expertise aids in her current mission to promote and advance AI-driven drug discovery initiatives at BenevolentAI, contributing to the organization's goal of finding new, life-changing medicines.